Apellis Pharmaceuticals Inc
NASDAQ:APLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
AU Small Finance Bank Ltd
NSE:AUBANK
|
IN |
|
Hyundai Motor Co
F:HYU
|
KR |
|
East Money Information Co Ltd
SZSE:300059
|
CN |
|
Aftermath Silver Ltd
XTSX:AAG
|
CA |
|
E
|
Endeavour Silver Corp
NYSE:EXK
|
CA |
|
H & R Block Inc
NYSE:HRB
|
US |
|
Sleep Country Canada Holdings Inc
TSX:ZZZ
|
CA |
|
Redcare Pharmacy NV
XETRA:RDC
|
NL |
|
C
|
China State Construction International Holdings Ltd
F:C4S1
|
HK |
|
Siemens Healthineers AG
OTC:SEMHF
|
DE |
|
Resonance Health Ltd
ASX:RHT
|
AU |
|
AxoGen Inc
NASDAQ:AXGN
|
US |
|
Obrascon Huarte Lain SA
MAD:OHLA
|
ES |
|
P
|
Pantheon Infrastructure PLC
LSE:PINT
|
UK |
|
Globalfoundries Inc
NASDAQ:GFS
|
US |
|
P
|
Puig Brands SA
MAD:PUIG
|
ES |
|
B
|
Blue Jet Healthcare Ltd
NSE:BLUEJET
|
IN |
|
P
|
Pick N Pay Stores Ltd
JSE:PIK
|
ZA |
|
Jacquet Metals SA
PAR:JCQ
|
FR |
|
S
|
Singapore Airlines Ltd
OTC:SINGF
|
SG |
Bankruptcy Probability
Apellis Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Apellis Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
5.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Apellis Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Apellis Pharmaceuticals Inc has total debt of 362.2m USD. This includes both short-term (0 USD) and long-term (362.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
